Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Respiratory Disease Testing industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Test type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Respiratory Disease Testing Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing government initiatives in developed and developing countries
3.2.1.2 Rising prevalence of chronic obstructive pulmonary disease (COPD)
3.2.1.3 Increasing healthcare spending by public and private organizations
3.2.1.4 Exposure to dust particles and increasing number of cigarette smokers in developing as well as underdeveloped regions
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of respiratory disease testing devices
3.2.2.2 Unfavorable reimbursement scenario
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By application
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Technological landscape
3.6 Regulatory Landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Becton Dickinson & Company
4.1.2 Koninklijke Philips N.V.
4.1.3 Abbott Laboratories
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Respiratory Disease Testing Market, By Test Type
5.1 Key segment trends
5.2 Mechanical tests
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Spirometry
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Peak-flow test
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Pulmonary function test
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Blood gas test
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.6 Others
5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Imaging tests
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 X-ray
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 CT-scan
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Ultrasonography
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.5 MRI
5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 In-vitro diagnostic tests
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Point-of-care test
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Molecular diagnostic test
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Others
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Respiratory Disease Testing Market, By Application
6.1 Key segment trends
6.2 Chronic obstructive pulmonary disease
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Lung cancer
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Asthma
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Tuberculosis
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Others
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Respiratory Disease Testing Market, By End-use
7.1 Key segment trends
7.2 Diagnostic centers
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Hospitals
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Clinics
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Respiratory Disease Testing Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Switzerland
8.3.7 Sweden
8.3.8 Poland
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Turkey
8.6.5 Egypt
8.6.6 Israel
8.6.7 Qatar
Chapter 9 Company Profiles
9.1 Becton Dickinson & Company
9.2 VYAIRE MEDICAL, INC
9.3 Koninklijke Philips N.V.
9.4 ResMed
9.5 Fischer & Paykel
9.6 Medtronic
9.7 CAREstream Medical, Ltd
9.8 Abbott Laboratories
9.9 Thermo Fischer Scientific Inc
9.10 Biomerieux
9.11 Cosmed
9.12 Siemens Healthineers
9.13 SDI Diagnostics
9.14 Seegene Inc
